GRACEcast

Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer


Listen Later

Immune checkpoint inhibitors are now becoming approved and commercially available for patients with previously treated advanced NSCLC. Dr. Eddie Garon, medical oncologist at UCLA, summarizes key data and explains their current role in treatment.

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD